Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: NCC-1911 D who wrote (349)	5/20/1998 11:26:00 PM
From: JEFF CHAPMAN	Respond to of 705

Sure there are other biotechs w/ a blockbuster hope. But NEOT has showed promise with its drug in humans for the specific disease of alzheimers, meaning the similar MABXA should benefit since it is using the same delivery technique as NEOT. The only 3 that should be discussed in this specific alzheimer's move are CORX, MABXA, and NEOT, imo.

To: NCC-1911 D who wrote (349)	5/21/1998 12:15:00 AM
From: slipnsip	Respond to of 705

What I find interesting is that a stock that is listed on SI under the $5 and under camp's thread is littered with most of the posts promoting other biotechs.. This would lead me to the conclusion that although the drug could have some potential (possibly huge), there are more traders traders than anything else. Thus I agree with the higher highs at the open with a sustained sell off over the next several weeks. Looking to short at the open. Guessing that as usual, I wont be able to find any..